Objective. CD4؉ T cells from patients with active lupus have impaired ERK pathway signaling that decreases DNA methyltransferase expression, resulting in DNA demethylation, overexpression of immune genes, and autoimmunity. The ERK pathway defect is due to impaired phosphorylation of T 505 in the protein kinase C␦ (PKC␦) activation loop. However, the mechanisms that prevent PKC␦ T 505 phosphorylation in lupus T cells are unknown. Others have reported that oxidative modifications, and nitration in particular, of T cells as well as serum proteins correlate with lupus disease activity. We undertook this study to test our hypothesis that nitration inactivates PKC␦, contributing to impaired ERK pathway signaling in lupus T cells.
Systemic lupus erythematosus (SLE) is an incompletely understood chronic, relapsing autoimmune disease. Persuasive evidence indicates that genetic factors contribute to disease development. However, a lack of complete disease concordance in identical twins and the relapsing nature of the disease indicate that environmental factors are important as well (1) . The full repertoire of the environmental factors, and the mechanism(s) by which the environmental agents contribute to the onset of lupus and lupus flares, remain unknown. Our group has reported that T cell DNA demethylation contributes to the pathogenesis of human lupus by causing overexpression of immune genes, leading to T cell autoreactivity and the development of lupus in genetically predisposed hosts (2) . This suggests that the environment may trigger lupus flares by inhibiting T cell DNA methylation. The mechanisms by which environmental agents cause T cell DNA demethylation in lupus are also unknown.
DNA methylation patterns are replicated each time a cell divides by DNA methyltransferase 1 (DNMT-1) (3), whose levels are regulated in part by the ERK signaling pathway (4) (5) (6) . We reported that treating proliferating T cells with ERK pathway inhibitors, such as hydralazine and U0126, or with DNMT inhibitors, such as procainamide, is sufficient to demethylate the DNA and that the demethylated T cells are sufficient to cause a lupus-like disease in murine models (7, 8) . Further, transgenic mice with an inducible T cell ERK pathway signaling defect develop a lupus-like disease (9) . We also reported that T cells from patients with active lupus have impaired ERK pathway signaling, low DNMT-1 levels, and overexpress methylation-sensitive genes (10) , suggesting that impaired ERK pathway signaling contributes to DNA demethylation in human lupus. Interestingly, CD4ϩ lupus T cells demethylate the same genetic regulatory elements demethylated by ERK pathway inhibitors and DNMT inhibitors (11) , and the level of lupus disease activity is directly related to the degree of signaling impairment and DNA demethylation (10) . These studies thus suggest an important role of impaired ERK pathway signaling in triggering lupus flares.
More recent studies traced the lupus ERK pathway signaling defect to impaired protein kinase C␦ (PKC␦) phosphorylation (12) . PKC␦ is a key molecule that is phosphorylated in response to a variety of signals, and thus activates other signaling pathways including the ERK pathway (13) (14) (15) . PKC␦ in T cells from patients with active lupus or in hydralazine-treated T cells is not properly phosphorylated in response to phorbol myristate acetate (PMA) or other stimuli, and the defect correlates with the lupus ERK pathway defect. Transfecting human T cells with a kinase-inactive PKC␦ causes decreased ERK phosphorylation, indicating that PKC␦ is critically required for ERK pathway activation. Additionally, the transfected cells exhibited demethylation and overexpression of the TNFSF7 (CD70) gene, similar to findings in lupus patients (12) . However, the mechanisms inhibiting PKC␦ phosphorylation in lupus T cells are unknown.
Inflammation is associated with the generation of reactive oxygen species (ROS), and patients with active lupus have increased levels of ROS and reactive nitrogen intermediates (RNIs), as well as decreased levels of oxidant scavengers (16) (17) (18) . This imbalance causes increased levels of superoxide (O 2 Ϫ ), hydrogen peroxide (H 2 O 2 ), and peroxynitrite (ONOO Ϫ ), all highly reactive metabolites that cause direct toxicity by inducing chemical modifications in lipids, proteins, and DNA (19) . ONOO Ϫ nitrates Tyr residues to prevent phosphorylation (20) and may thus affect signaling pathways. However, the consequences of oxidative stress on T cell signaling are also poorly understood.
Since T cell PKC␦ kinase activity is decreased in patients with active lupus and active lupus is characterized by the generation of ROS/RNIs and oxidative protein damage, we hypothesized that PKC␦ may be covalently modified by ROS/RNIs in lupus T cells, preventing its activation. The goal of this study was to determine if oxidative modifications produced by ONOO Ϫ contribute to impaired T cell PKC␦ phosphorylation, causing the decreased ERK pathway signaling observed in patients with active lupus.
MATERIALS AND METHODS
Reagents. Hydralazine was purchased from VWR and peroxynitrite from Calbiochem. All other chemicals were from Sigma.
Antibodies. The following primary antibodies were used: polyclonal rabbit anti-phospho-PKC␣ (at T 638/641 ), anti-phospho-PKC (at T 538 ), anti-phospho-PKC␦ (at T 505 ), anti-phospho-PKC␦ (at Y 311 ), and anti-phospho-3Ј-phosphoinositidedependent protein kinase 1 (anti-phospho-PDK-1) (at Ser 241 ), at 1:1,000 dilution (Cell Signaling Technology). For immunoprecipitation, antinitrotyrosine, clone 1A6 agarose conjugate, was used (Millipore). Rabbit polyclonal anti-active MAPK (1:5,000) was from Promega, and anti-total PKC␦ was from Santa Cruz Biotechnology. Secondary antibodies included horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (1:2,000 dilution; Cell Signaling Technology) and HRPconjugated anti-mouse IgG (1:4,000 dilution; Amersham).
Subjects. Sixteen lupus patients (mean age 42 years, range 27-64 years) with active or inactive disease were recruited from the outpatient rheumatology clinics and inpatient services at the University of Michigan, and 21 healthy controls were recruited by advertising. All lupus patients met the American College of Rheumatology revised criteria for SLE (21) . Lupus disease activity was quantified using the SLE Disease Activity Index (SLEDAI) (22) , and the range was 4-10 (mean 6.2) for the patients with active lupus and 0-2 (mean 0.5) for the patients with inactive disease. Controls were matched to the lupus patients for age, race, and sex. These protocols were reviewed and approved by the University of Michigan Institutional Review Board for Human Subject Research. The demographics of the patients and the medications they received are summarized in Table 1 .
T cell isolation. Peripheral blood mononuclear cells were isolated from healthy donors or SLE patients by FicollHypaque density-gradient centrifugation. CD4ϩ T cells were then purified by negative selection using magnetic beads (CD4ϩ T cell isolation kit; Miltenyi Biotec) as previously reported (12) . T cell stimulation and protein isolation. CD4ϩ T cells were suspended in RPMI 1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine, and penicillin/streptomycin, and then were left unstimulated or were stimulated with 50 ng/ml PMA for 15 minutes at 37°C. Treatment with peroxynitrite was performed at the concentrations and times specified in each experiment and before PMA stimulation. Following stimulation, whole cell lysates were obtained according to previous protocols (12) , and protein content was quantified using the BCA Protein Assay (Pierce).
Transient transfection. T cells from normal donors were immediately transfected with small interfering RNA (siRNA) or the indicated mutants using Amaxa nucleofection technology according to previous protocols (12) . After 24 hours, the cells were treated as indicated, harvested, and cell lysates were obtained as above. Small interfering RNA protein phosphatase 2Ac (PP-2Ac) and PP-2Ac mutants H118N and L199P were kindly provided by Dr. G. Tsokos and used as described by Katsiari et al (23) . The mean Ϯ SD transfection efficiency was 63 Ϯ 6% of the total cell number and was verified by fluorescence microscopy of cells transfected with the positive control vector pmaxGFP, which encodes a green fluorescent protein (GFP) and was provided with the kit.
Immunoblot analysis. Immunoblots were performed as previously described (12) . Briefly, 20 g of whole cell protein was fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to nitrocellulose membranes (Schleicher & Schuell), and then stained with ponceau S (Sigma) to verify equal protein loading between lanes. After incubation with the kinase-specific antibody and then with the secondary antibody, protein bands were visualized by chemiluminescence (Amersham). The bands on x-ray films were scanned and analyzed with ImageQuant 5.2 software (Amersham) for quantification. Where indicated, blots were stripped and reprobed with the corresponding antibody. Values were normalized to ␤-actin or the corresponding kinase, as indicated.
Immunoprecipitation. Immunoprecipitation was performed according to the manufacturer's instructions. Briefly, lysates from normal or lupus T cells were incubated with the agarose-conjugated antinitrotyrosine antibody overnight at 4°C. Following centrifugation, an aliquot of the supernatant (containing non-nitrated proteins) and the beads were resuspended in Laemmli sample buffer and boiled for 5 minutes. Proteins from each fraction were then analyzed in parallel by SDS-PAGE and immunoblot analysis.
Statistical analysis. The significance of the difference between means was determined using Student's t-test, regression analysis, or analysis of variance as appropriate. P values less than or equal to 0.05 were considered significant.
RESULTS

PDK-1 does not contribute to the PKC␦ signaling defect in lupus T cells.
We examined the mechanisms regulating PKC␦ phosphorylation to determine the causes of the lower levels of phosphorylated T 505 in PKC␦ in PMA-stimulated lupus T cells. PDK-1 controls the phosphorylation of T 505 in the PKC␦ catalytic loop (24) . We therefore examined PDK-1 activation. (25) . PDK-1 activation was therefore studied using antibodies to PDK-1 phospho-Ser 241 and immunoblotting. There was no significant difference in PDK-1 phosphorylation between control and lupus T cells, although phosphorylation of T 505 in PKC␦ was decreased in PMAstimulated CD4ϩ T cells from lupus patients with active disease ( Figure 1A ). The densitometric analysis of 4 similar experiments confirmed no significant difference in PDK-1 activation between lupus patients and controls (P Ͼ 0.05) ( Figure 1B ). Our observation that phospho-PDK-1 is expressed at similar levels in resting and PMA-stimulated T cells is concordant with the observation that PDK-1 is constitutively active due to autophosphorylation of its activation loop (26) . These results indicate that a PDK-1 activity defect is not likely to be causing the decreased phosphorylation of T 505 in PKC␦ in CD4ϩ lupus T cells.
ONOO ؊ inhibits phosphorylation of T 505 in PKC␦. Oxidative stress plays an important role in triggering lupus flares, and others have reported that serum protein oxidation correlates with disease activity in lupus patients and that serum proteins are abnormally nitrated in patients with active lupus (16, 27 (Figure 2A ). Figure 2B shows the quantitative densitometric analysis of 4 serial repeat experiments similarly measuring the effects of ONOO Ϫ on the phosphorylation of T 505 in PKC␦. These results indicate that the inhibitory effects of ONOO Ϫ on PKC␦ are isoform specific, since phosphorylation of other isoforms was unaffected. Since ONOO Ϫ nitrates Tyr residues to form 3-nitrotyrosine (20) , we confirmed the effect of ONOO Ϫ by measuring 3-nitrotyrosine protein derivative formation. CD4ϩ T cells from a healthy donor were treated with increasing concentrations of ONOO Ϫ and then stimulated with PMA. Proteins modified by 3-nitrotyrosine were studied by immunoblotting. We observed a concentration-dependent increase in 3-nitrotyrosine derivative formation ( Figure 2C ). Figure 2D shows the mean Ϯ SEM values from densitometric analyses from 4 similar experiments, confirming that T cell proteins are nitrated by ONOO Ϫ and that their nitration levels correlate with the ONOO Ϫ -induced inhibition of phosphorylation of T 505 in PKC␦ shown in Figure 2B . We also studied the phosphorylation of Y 311 in the PKC␦ molecule, because this amino acid is phosphorylated in cells undergoing oxidative stress (28, 29) . Figure 3A shows Figure 3A) .
PP-2Ac does not participate in the ONOO ؊ -induced PKC␦ defect. ONOO Ϫ increases PP-2Ac activity in some cell types (30) , and PP-2Ac has the highest specific phosphatase activity toward PKC␦ (31) . Further, PP-2Ac expression and activity are increased in T cells from lupus patients (23) . We tested whether increased PP-2Ac activity could be responsible for the PKC␦ dephosphorylation caused by ONOO Ϫ . T cells from healthy donors were transfected either with 5 g of plasmids encoding the dominant-negative PP-2Ac mutants H118N or L199P (32) or with 100 nM PP-2Ac-specific siRNA according to Katsiari et al (23) . Cells transfected with an irrelevant siRNA were used as control, and 2 g of the empty GFP vector was transfected as an internal control for transfection efficiency in each experiment. Twenty-four hours later, the cells were treated with ONOO Ϫ for 15 minutes followed by PMA stimulation. In 3 serial repeat experiments, relative to PMA-stimulated T cells (set at 100%), phosphorylation at T 505 in PKC␦ was not increased in ONOO Ϫ -treated cells overexpressing the catalytically inactive PP-2Ac Figure 4A shows that, as expected, PMA-stimulated ERK phosphorylation declined with increasing ONOO Ϫ concentrations and paralleled the decrease in PKC␦ T 505 phosphorylation. This is consistent with our previous results showing that PKC␦ T 505 phosphorylation is upstream of ERK (12) and its impairment decreases ERK pathway signaling. Figure 4B shows the quantification of 4 serial repeat experiments confirming this observation.
PKC␦ nitration in lupus. Lupus is characterized by increased oxidative stress (16, 33, 34) . T cells from patients with active lupus generate large amounts of ROS (35) , and serum proteins are nitrated in these patients (36) . We therefore hypothesized that PKC␦ is inactivated in T cells from patients with active lupus through nitration, similar to ONOO Ϫ -treated T cells. To address this hypothesis, CD4ϩ T cells from 6 lupus patients with active disease (SLEDAI score Ն4) were stimulated with PMA, and nitrated proteins were immunoprecipitated from the lysates with anti-3-nitrotyrosine antibodies. Results were compared to similarly treated CD4ϩ T cells from 4 lupus patients with inactive disease. Controls included CD4ϩ T cells from 3 healthy subjects that were left untreated or were treated with ONOO Ϫ followed by PMA stimulation. Total PKC␦ and PKC␦ phospho-T 505 content were then compared by immunoblotting.
Nitrated and non-nitrated PKC␦ were analyzed as the total PKC␦ content in the precipitate and supernatant, respectively. The levels of total PKC␦ (supernatant plus immunoprecipitate) were similar in untreated or ONOO Ϫ -treated T cells from control donors and lupus patients (Figures 5A and B) . These results confirm previous data showing no differences in PKC␦ protein expression in control donors and lupus patients (12) . As anticipated, the amount of nitrated PKC␦ (precipitated) was higher in T cells from patients with active lupus relative to controls (P Յ 0.03) and with a pattern similar to that in ONOO Ϫ -treated control T cells ( Figure 5A ). In contrast, Figure 5B shows that the patterns of nitration and phosphorylation of PKC␦ did not differ significantly in CD4ϩ T cells from patients with inactive lupus when compared to CD4ϩ T cells from healthy controls. Importantly, the level of T cell PKC␦ nitration in lupus patients correlated directly with the SLEDAI scores ( Figure 5C ).
However, overall T 505 phosphorylation in PKC␦ was decreased in stimulated T cells from patients with active lupus relative to those from healthy controls (P ϭ 0.04) ( Figure 5B), and the nitrated PKC␦ fraction from the patients with active lupus was almost completely refractory to PMA-stimulated phosphorylation (mean Ϯ SEM 4 Ϯ 2% of nitrated PKC␦) (P Յ 0.04 for patients with active lupus versus healthy controls) ( Figure 5A ). As predicted, 74% of the PKC␦ in T cells treated with ONOO Ϫ was nitrated, but only 6% of this fraction was phosphorylated at T 505 after PMA stimulation ( Figure 5A ). In contrast, non-nitrated PKC␦ was phosphorylated in T cells from healthy controls and from patients with active or inactive lupus (supernatant) ( Figure 5A) . These experiments thus demonstrate more extensive PKC␦ nitration, and less T 505 phosphorylation, in T cells from patients with active lupus relative to those from patients with inactive lupus and healthy controls, suggesting that T 505 phosphorylation decreases in proportion to the extent of nitration and that the degree of nitration is directly related to the disease activity. Figure 5 . PKC␦ nitration in lupus T cells. CD4ϩ T cells from 3 healthy donors (control) were left untreated or were treated with peroxynitrite (ONOO Ϫ ) followed by stimulation with PMA. In parallel, CD4ϩ T cells from 6 patients with active lupus and 4 patients with inactive lupus were stimulated with PMA. Total lysates were immunoprecipitated, and then supernatants (spnt) and precipitates (pp) were immunoblotted with an antibody against PKC␦ phospho-T 505 . Membranes were reprobed with an antibody against total PKC␦. A, Quantitative densitometric analysis of total PKC␦ and PKC␦ phospho-T 505 in the supernatant and the precipitate using CD4ϩ T cells from healthy donors and patients with active disease. Values are the mean Ϯ SEM of 6 independent experiments. ‫ء‬ ϭ P Յ 0.01; ‫ءء‬ ϭ P Յ 0.04; # ϭ P Յ 0.03. B, Nitrated PKC␦ (total PKC␦ content in precipitate) and PKC␦ phospho-T 505 (phosphorylated PKC␦ in supernatant plus precipitate) as a percentage of the total PKC␦ (expressed in arbitrary units) in supernatant and precipitate under each experimental condition. Values are the mean Ϯ SEM of 6 experiments. P values are versus control cells not treated with ONOO Ϫ . C, Correlation between nitrated PKC␦ levels in lupus patients and scores on the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). The P value was determined by analysis of variance. IP ϭ immunoprecipitation; WB ϭ Western blotting (see Figure 1 for other definitions).
DISCUSSION
The goal of this study was to investigate mechanisms causing the PKC␦ phosphorylation defect responsible for decreased ERK pathway signaling in lupus T cells. PKC␦ belongs to the PKC family of related serine/ threonine kinases with active roles in growth regulation and apoptosis. PKC isoforms contain a highly conserved C-terminal catalytic domain. However, they are subdivided into 3 subfamilies according to their N-terminal regulatory domains. Conventional isoforms comprise PKC␣, PKC␤, and PKC␥, bind diacylglycerol (DAG)/ PMA in their C1 domain, and bind anionic phospholipids in a calcium-dependent manner in their C2 domain. Novel isoforms include PKC␦, PKC, PKC, PKC, and PKC and are activated by DAG/PMA without a calcium requirement. Atypical isoforms, PKC and PKC/, are DAG/PMA and calcium independent (37) .
PKC␦ is ubiquitously expressed among cells and tissues and is the only isoform that can be activated by 3 different mechanisms: through Ser/Thr phosphorylation, through tyrosine phosphorylation, and by caspase 3-dependent proteolytic cleavage. These are independent mechanisms that regulate PKC␦ activity, substrates, and cellular localization and play critical roles during cell growth, differentiation, and programmed cell death as well as the cellular response to oxidative stress (38) .
Our previous work identified decreased PKC␦ phospho-T 505 levels in stimulated lupus T cells, which correlated with the decreased ERK pathway signaling previously reported in lupus T cells. We also demonstrated that PKC␦ is upstream of ERK and that impaired PKC␦/ERK pathway signaling in T cells causes demethylation and overexpression of methylationsensitive genes (12) . Importantly, transgenic mice lacking T cell PKC␦ activity develop a lupus-like disease with decreased ERK signaling, overexpression of methylationsensitive genes, and production of anti-double-stranded DNA antibodies similar to those observed in lupus patients (ref. 39 and Gorelik GJ, et al: unpublished observations), strongly supporting the hypothesis that defective PKC␦ signaling is sufficient to cause lupus.
PDK-1 phosphorylates PKC␦ at T 505 in the activation loop, promoting alignment of these residues with the catalytic pocket and controlling catalytic activity of the enzyme (24) . We demonstrated that phosphorylation of Ser 241 , which is required for PDK-1 kinase activity, is not appreciably affected in lupus T cells relative to T cells from healthy donors and under the same assay conditions in which PKC␦ phospho-T 505 levels were decreased. This implies that another mechanism inhibits phosphorylation at T 505 in PKC␦ in lupus T cells.
Chronic inflammation is associated with oxidative stress, and a prooxidative state has been described in patients with lupus (27, 34) . In this prooxidative state, higher levels of ROS/RNIs are present and can directly cause toxicity through posttranslational modifications of proteins and alterations of lipids and DNA. Nitric oxide (NO) is overproduced in lupus (40) and can combine with O 2 Ϫ to form ONOO Ϫ , a highly reactive and potentially pathogenic molecule. Multiple markers of protein oxidation have been found in SLE patient sera, including protein carbonyls, protein-bound methionine sulfoxide, decreased levels of protein thiols (27) , and increases in protein 3-nitrotyrosines that correlate with worsening disease status (16, 33, 41) , indicating that protein oxidation and, in particular, nitrating pathways may play an important role in the pathogenesis of SLE (33, 34, 36) . However, while it is recognized that overproduction of ROS/RNIs alters and modifies T cell signaling, their target molecules and the intracellular mechanisms that they affect are not well understood.
Based on these observations, we investigated whether the defective PKC␦ activation in lupus T cells was caused by oxidative damage. ONOO Ϫ was used as the oxidizing agent and caused PKC␦ nitration that resulted in decreased phosphorylation of T 505 . The fact that PKC␦ was the only PKC isoform catalytically affected indicates that the ONOO Ϫ inhibitory effect is selective and specific to PMA-stimulated PKC␦ phospho-T 505 . PKC␦ is not phosphorylated at the activation loop (T 505 ) in resting T cells, but phosphorylation increases following PMA stimulation and translocation to the cytoplasmic membrane. In our studies, oxidation modified the phosphorylation pattern, increasing tyrosine phosphorylation while decreasing threonine phosphorylation, indicating specific effects on PKC␦ phosphorylation regulation. This differential pattern of PKC␦ phosphorylation also modifies its intracellular translocation, resulting in changes to the interaction of PKC␦ with downstream targets (42) . Recent studies indicate that ROS can also modulate PKC␦ activity in other cell types. In keratinocytes, oxidation increases PKC␦ tyrosine phosphorylation, resulting in reduced enzymatic activity (43) , whereas in other cells, oxidation enhances the enzymatic activity (44) or even modifies the enzymatic specificity (45) , indicating that oxidative modifications of PKC␦ activity may be cell type dependent and/or phosphorylated residue dependent (28) . The precise effects of oxidation on T cell PKC␦ have not been explored, but it is possible that oxidation of certain residues in the molecule causes distortions in the secondary and tertiary structure, resulting in decreased accessibility of T 505 to phosphorylation. It is also possible that the rate of dephosphorylation increases with oxidation.
The phospho-serine/threonine phosphatases PP-1c, PP-2Ac, and PP-2C␣ dephosphorylate PKC␦, with PP-2Ac demonstrating the highest specific activity toward PKC␦ (31) . However, our results show that T cells transfected with catalytically inactive PP-2Ac mutants or with the corresponding siRNA did not restore PKC␦ phosphorylation following ONOO Ϫ treatment, suggesting that modifications of PP-2Ac activity are unlikely to be responsible for the decreased T 505 phosphorylation observed in oxidized PKC␦. This observation is consistent with a study demonstrating that even though the messenger RNA, protein, and enzymatic activity of the PP-2A catalytic subunit (PP-2Ac) is increased in patients with lupus, the defect is independent of disease activity (23) , while the PKC␦ phosphorylation impairment is directly related to disease activity (12) . The present work shows that oxidation of PKC␦ results in a selective decrease in PKC␦ phospho-T 505 levels and directly correlates with decreased phospho-ERK levels in T cells, consistent with our previous results.
The consequences of an oxidative environment on ERK activity are not clearly defined and vary depending on the cell system and stimulus. Decreased phosphorylation of ERK induced by ONOO Ϫ in kidneys of ␤ s sickle cell mice has been reported (46) , and similarly, an alteration of the cellular redox state leads to increased MAPK phosphatase 1 expression in fibroblasts, resulting in ERK inactivation (47) . This suggests that additional mechanisms may contribute to the decreased ERK phosphorylation caused by oxidative stress in lupus T cells. ONOO Ϫ may alter protein structure and function by interacting with different amino acids. By oxidating cysteine residues (S-nitrosylation), ONOO Ϫ inactivates many enzymes involved in energetic processes in addition to protein tyrosine phosphatases that may enhance tyrosine phosphorylation-dependent signaling (20) . ONOO Ϫ also oxidizes tyrosine residues (O-nitration) to form 3-nitrotyrosine derivatives (20) . Tyrosine nitration is considered to be a major cause of ONOO Ϫ -mediated cytotoxicity because it affects protein structure and function that may result in the generation of antigenic epitopes (48) , changes in the catalytic activity of enzymes, and impaired cell signal transduction (49) . Nitration is a highly selective process limited to specific tyrosine residues on a limited number of proteins. In general, protein nitration is associated with loss of function (46) . Others have reported an increased amount of NO-mediated oxidation products, such as 3-nitrotyrosine proteins, due to elevated levels of ONOO Ϫ in the serum of lupus patients (41) . We found higher levels of nitrotyrosine-containing proteins in T cells from patients with active lupus than in T cells from patients with inactive lupus or in T cells from healthy controls. The levels of nitrated PKC␦ were also greater in T cells from patients with active lupus, and PMA-stimulated T 505 phosphorylation of the nitrated proteins was impaired. Similar results were observed in control T cells pretreated with ONOO Ϫ . Therefore, the presence of significant levels of nitrated PKC␦ in T cells from patients with active lupus may explain the decrease in PKC␦ phospho-T 505 levels observed in T cells from lupus patients, the consequent decrease in ERK signaling pathway, and their correlation with disease severity. Protein nitration is often associated with pathologic states related to inflammation, but is also recognized as a normal physiologic process (20) , suggesting an explanation for the presence of nitrated proteins in T cells from healthy donors and patients with inactive lupus. The relatively lower level of PKC␦ phosphorylation that we found in normal T cells in the nitrated fraction could be due to a lesser degree of oxidation that normally takes place during physiologic metabolism. However, our studies also demonstrate that human T cell PKC␦ is directly modified by oxidation. The oxidation selectively decreases PMA-stimulated PKC␦ T 505 phosphorylation and is directly related to a decrease in ERK signaling, suggesting that higher levels of nitration cause structural changes in PKC␦ that make it catalytically inactive.
Our study reveals that the impaired T cell PKC␦ kinase activation observed in patients with active lupus is likely due to oxidative damage and causes the impaired ERK pathway signaling in T cells from lupus patients. These studies point to PKC␦ as a link between oxidative stress, caused by environmental agents, and the epigenetic changes observed in lupus T cells. Other poorly understood autoimmune diseases also result from geneenvironment interactions and involve epigenetic mechanisms that include not only DNA methylation, but also histone modifications and microRNA (50) . Oxidative stress may also contribute to these disorders through mechanisms such as altered signaling. 2972 GORELIK ET AL
